Despite Its Recent Partnership with Apple, MP Materials Stock Is Down. Here's Why.

MP Materials remains strategically important, but its stock is revaluing lower in 2026 despite major Apple and Department of Defense deals last year. The article cites a still-stretched valuation at roughly 37x sales and more than 450x forward earnings, plus signs that U.S.-China rare-earth export negotiations could temporarily ease supply pressure. The core message is that MP's business is improving, but the market no longer appears willing to price it as a proxy for a fully rebuilt domestic rare-earth supply chain.

Analysis

The key market misread is treating strategic scarcity as a near-term earnings multiple anchor. MP’s real option value depends less on current output and more on whether downstream processing, magnetization, and customer qualification can scale fast enough to de-risk the “non-China” supply chain; that is a multi-year industrial build, not a one-quarter geopolitical headline. If policy pressure eases even temporarily, the stock can compress hard because the equity has been pricing a quasi-sovereign monopoly rather than a cyclical miner with execution risk.

The second-order winner from any China easing is not necessarily Chinese supply, but OEMs and defense primes that need continuity at the lowest possible input volatility. Apple benefits from more optionality and less urgency premium in procurement, while defense contractors gain if the government can reduce single-name concentration risk without paying up for scarcity. The hidden loser is every aspirational Western rare-earth entrant: a softer policy backdrop lowers the probability of urgent domestic capex, pushes out financing timelines, and makes customer offtake commitments harder to secure.

The catalyst structure is asymmetric. In the next 1-3 months, headline-driven multiple compression can continue if trade rhetoric stays constructive, because valuation is doing most of the work here, not fundamentals. Over 12-24 months, though, any re-tightening of export controls or a credible disruption in non-China supply would snap the narrative back violently; this is a classic policy beta name with reflexive upside if the market realizes the domestic build remains incomplete.

Consensus is missing that MP can be strategically important without being financially cheap. That distinction matters: the market may be overpricing immediacy and underpricing execution bottlenecks, but it may also be underpricing the probability that policy swings create repeated entry points rather than a straight-line rerating. For now, the cleaner trade is to express skepticism through valuation, not through a structural short of the entire thematic basket.

Key Decisions for Investors

• Short MP into strength or use call overwrites for the next 1-3 months; thesis is multiple compression as policy easing reduces scarcity premium. Risk: a fresh geopolitical escalation can reflate the stock quickly.
• Relative value: long AAPL / short MP for 1-2 quarters. Apple gets supply-chain optionality without single-asset execution risk; MP remains exposed to valuation and policy beta. Target is modest downside in MP versus lower beta in AAPL.
• Pair trade: long defense prime basket vs short MP on any China-friendly headline. If supply chain de-risking becomes the market narrative, defense names should hold better because budgeted procurement is less sensitive to input volatility than MP’s equity multiple.
• Avoid chasing MP after gap-downs until valuation resets toward a more normal industrial range; if the stock remains above ~25-30x sales, upside is still dominated by sentiment rather than fundamentals.
• For tactical upside exposure, prefer call spreads over outright longs if you need to own the theme; the policy headline risk is binary and implied volatility should stay rich, making defined-risk structures superior.